Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Profound Medical (PROF) Return on Capital Employed (2019 - 2026)

Profound Medical has reported Return on Capital Employed over the past 7 years, most recently at 11.8% for Q4 2025.

  • For Q4 2025, Return on Capital Employed rose 5500.0% year-over-year to 11.8%; the TTM value through Dec 2025 reached 11.8%, up 5500.0%, while the annual FY2025 figure was 9.37%, 5606.0% up from the prior year.
  • Return on Capital Employed for Q4 2025 was 11.8% at Profound Medical, up from 117.15% in the prior quarter.
  • Over five years, Return on Capital Employed peaked at 43.27% in Q3 2021 and troughed at 194.33% in Q2 2023.
  • A 5-year average of 69.75% and a median of 68.48% in 2023 define the central range for Return on Capital Employed.
  • On a YoY basis, Return on Capital Employed climbed as much as 7357bps in 2024 and fell as far as -11368bps in 2024.
  • Year by year, Return on Capital Employed stood at 35.22% in 2021, then crashed by -52bps to 53.48% in 2022, then tumbled by -31bps to 70.17% in 2023, then increased by 5bps to 66.79% in 2024, then skyrocketed by 82bps to 11.8% in 2025.
  • Business Quant data shows Return on Capital Employed for PROF at 11.8% in Q4 2025, 117.15% in Q3 2025, and 85.41% in Q2 2025.